← Leaderboards
Hyo Sik Jang
Van Andel Research Institute
$555,320
Attributed
$555,320
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.2K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$555,320 · 2
By mechanism
K99$306,320 · 1
R00$249,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Van Andel Research Institute
Same institution · by research overlap
- H Eric Xu$10,075,813
- Eric Daniel Achtyes$1,449,656
- Nagy A. Youssef$229,863
Others in their field
Other Rising Stars on “Adverse Event”
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,688,224
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EventAdvisory CommitteesAnti-Pd-L1 TherapyAryl Hydrocarbon ReceptorAryl Hydrocarbon Receptor LigandBasic ScienceBindingBladderBladder NeoplasmCancer BiologyCancer CellCancer PatientCancer TherapyCancer TypeCarcinogensCareerCellsCell TypeCellular Indexing Of Transcriptomes And Epitopes By SequencingCessation Of LifeCheckpoint TherapyClinical TrialsCyp1a1 GeneAcceleration
Grant awards (3)
The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer$249,000
R00 · FY2025 · CA · contact PI
The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer$153,160
K99 · FY2025 · CA · contact PI
The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer$153,160
K99 · FY2024 · CA · contact PI